Insomnia in Patients With Metastatic Lung Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
This study evaluates how common insomnia (difficulties with sleep) is in patients with lung cancer that has spread from where it first started (primary site) to other places in the body.
Eligibility criteria
Qualifiers
Have a diagnosis of metastatic non small cell lung cancer
Undergoing 1st, 2nd or 3rd line of treatment or are in maintenance therapy
Older than 18 years old at the time of diagnosis
Disqualifiers
Subjects will be excluded if they are considered to have advanced terminal cancer, severe depression or other psychiatric disorder or a sleep disorder other than insomnia (sleep apnea, restless leg syndrome, sleep related disorder of breathing), regular use of psychotropic medication other than hypnotics (eg antidepressants) per chart review
Trial design
Treatments tested in this trial
- Non-Interventional Study
Treatment groups
60 Participants
are divided into 1 treatment groupLocations
1Mayo Clinic in Rochester55905, RochesterMinnesota, United States
Sponsors and collaborators
Mayo Clinic
Lead sponsor
Source ClinicalTrials.gov